AUTHORSHIP, MEMBERSHIP, DISCLOSURE STATEMENTS, COPYRIGHT, AND LICENSE

AGREEMENT
29 OCTOBER 2021

This AUTHORSHIP, MEMBERSHIP, DISCLOSURE STATEMENTS, COPYRIGHT, AND LICENSE AGREEMENT encompasses all aspects related
to our original cover page, acknowledgement and ethical consideration statements, account details, declarations, and publication
license forms. All fields are to be completed and submitted to AOSIS as a supplementary document, at the manuscript submission
point, onto the journal website.

Date completed Click or tap to enter a date.

1. MY MANUSCRIPT
At the time of submission of a manuscript, the journal requires you to choose one of the authors as the corresponding author. The
corresponding author is the one who receives all notifications from the journal, including manuscript status, reviewers’ comments, and
the final decision. The corresponding author should always be the submitter of the manuscript.
1.1 Corresponding Author (Submitter) COMPULSORY SUBSECTION
Salutation (e.g. Dr, Prof.) M.Th
Full Name and Surname Harman Ziduhu Laia / Harman
Skype Name      
Office Telephone Country calling code: +62 Number: 85791113812
Mobile Phone Country calling code: +62 Number: 82139321681
Email [email protected]
Alternative Email [email protected]
Physical address (incl. city and country) Jl. Dukuh Kupang Barat 1 No. 76-78 - Surabaya

Any special consideration when communicating with you (e.g. time of day to receive      
phone calls)
1.2 Overview COMPULSORY SUBSECTION
Full Title of Manuscript HOW LONG DID THE ISRAELITES LIVE IN EGYPT?
Number of Authors 3
Keywords (minimum 5, up to 10) Israel; Egypt; Lived; Enslaved; Persecuted; 215 Years
1.3 Preprint Server COMPULSORY SUBSECTION
Preprint Status Posted Not Posted
Date Posted Click or tap to enter a date.
Preprint Server Name      
Your preprint manuscript DOI      
2. MY INVOICE SHOULD GO TO - ARTICLE PROCESSING CHARGES (APC)
Find more information about article processing charges on the journal’s website, under the ‘Authors’ tab. Please provide the details of
the person or institution that will pay the APCs. Ensure that you have obtained approval from your institution for the estimated expense
before you submit your manuscript:
 The APC Invoice will be sent to the corresponding author on acceptance after formal peer review.
 Payment terms are 30 Days.
 Invoice must be paid in full before the accepted manuscript is published.

Frequently Asked Question for a Society Member: I am a member of the sponsoring society; will I pay an article processing fee? The
journal has limited funds available to society members for sponsoring their Article Processing Charges. Once all available funds have been
allocated, authors of subsequent submissions will be required to pay an APC to cover the full production costs of their article. Please

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 consult the Publication Fees tab on the journal website regularly for updates on the available funds.

2.1 Institution/Organisation COMPULSORY SUBSECTION

Full name of Institution/Organisation Sekolah Tinggi Teologi Injili Indonesia Surabaya (Evangelical Theological
Seminary of Indonesia Surabaya)
Department Name Theology
Faculty Name Theology, Education
Physical Address Jl. Raya Panjang Jiwo Permai no. 1C
City Surabaya
Province/state East Java
Postal code 60299
Country Indonesia
2.2 Finance department contact and credentials COMPULSORY SUBSECTION
VAT Number --
Cost Centre Theological Research Unit
Research Project Number 020021
Finance Department Contact Name Rumiyati Rumiyati
Finance Department Contact Email [email protected]
Finance Telephone Number +6281230431456
Invoice Currency ZAR (South African Rand) USD (United States Dollar)
3. OUR MEMBERSHIP CONFIRMATION (IF APPLICABLE) COMPULSORY SECTION
Are you an affiliated journal society member? If yes, kindly provide the sponsoring society membership number for each contributing
author (if applicable). Regularly consult the Publication Fees tab on the journal website for guidance on the society membership benefit.

Frequently Asked Question for a Society Member: I am a member of the sponsoring society; will I pay an article processing fee? The
journal has limited funds available to society members for sponsoring their Article Processing Charges. Once all available funds have been
allocated, authors of subsequent submissions will be required to pay an APC to cover the full production costs of their article. Please
consult the Publication Fees tab on the journal website regularly for updates on the available funds.
Author Initials Membership Number
Author 1 Full Name and Surname: Harman Ziduhu Laia Author 1 Membership No.:      
Author 2 Full Name and Surname: Daniel Ari Wibowo Author 2 Membership No.:      
Author 3 Full Name and Surname: Julitinus Harefa Author 3 Membership No.:      
Author 4 Full Name and Surname:       Author 4 Membership No.:      
Author 5 Full Name and Surname:       Author 5 Membership No.:      
Author 6 Full Name and Surname:       Author 6 Membership No.:      
Author 7 Full Name and Surname:       Author 7 Membership No.:     
Author 8 Full Name and Surname:       Author 8 Membership No.:      
Author 9 Full Name and Surname:       Author 9 Membership No.:      
Author 10 Full Name and Surname:       Author 10 Membership No.:      
4. AUTHORSHIP COMPULSORY SECTION
Policy information about authorship. Complete the authorship list in the order of authors as it should appear on the published scientific
paper. The affiliations of authors must reflect their situation during the funding, conducting and completion of the research, i.e. where
the research was carried out. If an author has changed affiliation since the completion of the research, the author’s first affiliation must
still reflect the institution where the research was conducted, supported, and funded. The ORCID is mandatory for all authors - if you or
your co-authors do not have an account, please register by following this link https://orcid.org/register.

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 Author 1
First Name: Harman Middle Name: Ziduhu Surname: Laia
Mobile: 085791113812 Phone: 82139321681 Email: [email protected]
Country calling code: +62 Country calling code:       ORCID: https://orcid.org/0000-0002-0661-
8982
Affiliation 1 Department: Faculty: Institution/University: City: Country:
Research Practical Sekolah Tinggi Surabaya Indonesia
Theology Teologi Injili
Indonesia
Surabaya
(Evangelical
Theological
Seminary of
Indonesia
Surabaya)
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 1: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 2
First Name: Daniel Middle Name: Ari Surname: Wibowo
Mobile: 088989442127 Phone:       Email: [email protected]
Country calling code: +62 Country calling code:       ORCID: https://orcid.org/ 0000-0003-4949-
5473
Affiliation 1 Department: Faculty: Institution/University: City: Country:
Biblical Studies Practical Sekolah Tinggi Surabaya Indonesia
Theology Teologi Injili
Indonesia
Surabaya
(Evangelical
Theological
Seminary of
Indonesia
Surabaya)
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 2: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 3
First Name: Julitinus Middle Name:       Surname: Harefa
Mobile: 082191306517 Phone:       Email: [email protected]
Country calling code: +62 Country calling code:       ORCID: https://orcid.org/0000-0001-8920-
7523
Affiliation 1 Department: Faculty: Institution/University: City: Country:
Research Practical Sekolah Tinggi Surabaya Indonesia
Theology Teologi Sola
Gratia Indonesia
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 3: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 4
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 4: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 5
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 Codes of authorship contribution for Author 5: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 6
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 6: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 7
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 7: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 8
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 8: Conceptualisation Software

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 9
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 9: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
Author 10
First Name:       Middle Name:       Surname:      
Mobile:       Phone:       Email:      
Country calling code:       Country calling code:       ORCID:      
Affiliation 1 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 2 Department: Faculty: Institution/University: City: Country:
                             
Affiliation 3 Department: Faculty: Institution/University: City: Country:
                             
Codes of authorship contribution for Author 10: Conceptualisation Software
Methodology Validation
Formal Analysis Data Curation
Investigation Resources
Writing – Original Draft Writing – Review & Editing
Visualisation Supervision
Project Administration Funding Acquisition
5. ACKNOWLEDGEMENT AND DISCLOSURE STATEMENTS
The acknowledgement section follows the conclusions section and addresses formal, required statements of gratitude, and required
disclosures. This information is not presented to reviewers during the peer review evaluation process; however, it will be published with
the accepted manuscript.
5.1 Acknowledgement statement COMPULSORY SUBSECTION
Policy information about acknowledgements. Please acknowledge those who contributed to the work but do not meet the authorship
criteria. Their names should be listed in the Acknowledgments, along with a description of the contribution. Authors are responsible for
ensuring that anyone named in the Acknowledgments agrees to be named. Please insert your full Acknowledgement Statement here:
The writing of this article is based on the scientific work of the three of us: Harman Ziduhu Laia, Daniel Ari
Wibowo, Julitinus Harefa

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 5.2 Competing interest statements COMPULSORY SUBSECTION
Policy Information about competing interests. In the interest of transparency and to help readers form their judgements of potential bias,
AOSIS journals require authors to declare any competing financial or non-financial interest to the work described in the submitted
manuscript. If none exist, please include ‘The authors have declared that no competing interest exists’. Please insert your Competing
Interest Statement here:
we writers have no special interest in the competition between writers. we just want to make useful writing

5.3 Author contribution statements COMPULSORY SUBSECTION

Policy information about authorship. All authors must meet the criteria for authorship as outlined in the authorship policy and author
contribution statement policies. Include a paragraph briefly summarising the nature of the contributions made by each of the authors
listed. Please insert your Author Contribution Statement here:
we collaborated to write this article by dividing tasks including the concept of mindset and also word analysis in
the original language of the Bible.

5.4 Funding statement COMPULSORY SUBSECTION

All manuscripts should have a funding acknowledgement statement (e.g. ‘This research received no specific grant from any funding
agency in the public, commercial, or not-for-profit sectors.’). If funding was received, the relevant grant number (or similar, as
applicable), should accompany the funding statement. Please insert your Funding Statement here:
We do not accept funds or donations in any form from donors or other related institutions in exchange for any
rewards or gifts from related institutions or institutions.

5.5 Data availability statement COMPULSORY SUBSECTION

All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: (a)
accession codes, unique identifiers, or web links for publicly available datasets, (b) a list of figures that have associated raw data, and (c) a
description of any restrictions on data availability. Please insert your Data Availability Statement here:
Do not have any figure

5.6 Disclaimer COMPULSORY SUBSECTION

Kindly update your disclaimer statement (e.g. ‘The views and opinions expressed in this article are those of the authors and do not
necessarily reflect the official policy or position of any affiliated agency of the authors). Please insert your Author(s) Disclaimer
Statement here:
The views and opinions expresed in this article are those of the authors and do not necessarily reflect the official
policy or position of any affiliated agency of the authors

6. ADDITIONAL POLICY DISCLOSURES COMPULSORY SECTION

Some types of research require additional policy disclosures. Please indicate where each of these applies to your study, if applicable, and
proceed to complete the relevant section. If you are unsure of whether these policy disclosures apply to your research, continue to read
the appropriate subsection before selecting a response.
Does not apply Involved in the study Topic
Complete 6.1 Relevant compliance (e.g. CONSORT, EQUATOR etc.) checklist as per journal submission
requirements
Complete 6.2 Unique biological materials
Complete 6.3 Ethical Considerations: Research animals and/or animal-derived materials that require
ethical approval
Complete 6.4 Ethical Considerations: Human embryos, gametes and/stem cells
Complete 6.5 Ethical Considerations: Human research participants
Complete 6.6 Ethical Considerations: Waiver received as research was not human or animal research,
or the study was determined to be on non-human subject research (e.g. use of historical
archives).
Complete 6.7 Clinical Data

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 6.1 Relevant CONSORT checklist
Policy information about the relevant compliance checklist is found on the compulsory forms page on the journal website.

I/we have completed the relevant compliance checklist and will upload it as a Supplementary file in the submission process.

6.2 Unique biological materials (if applicable)

Policy information regarding the availability of materials. Describe any restrictions on the availability of unique materials OR confirm
that all unique materials used are readily available from the authors or from standard commercial sources (and specify these sources).
     
I/we have described these restrictions in the manuscript.
I/we have described how to obtain all materials in the manuscript.
6.3-6.5 ETHICAL CONSIDERATIONS COMPULSORY SUBSECTION,
IF APPLICABLE
This information is not presented to reviewers during the peer review evaluation process; however, it will be published with the accepted
manuscript, if accepted after formal, double-blinded peer review.
6.3 Ethical Considerations: Research animals and/or animal-derived materials that require ethical approval
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research.
Please insert your Ethical Consideration This research which has been approved and examined by Sekolah Tinggi
statement here (include name of ethics Teologi Injili Indonesia Surabaya (Evangelical Theological Seminary of
committee, the institution or
organisation that approved the study Indonesia Surabaya), did not involving animals and/or animal derived
protocol or provided guidelines for study materials.
procedures):
Project Research Number: 020023
Ethical Clearance Number: o. 0045/KEP-STTII Sby/EC/III/2023
Date of approval of Ethical Clearance: February, 17th, 2023
I/we certify that the ethical clearance certificate, letter or any proof of the approval received for the study will be uploaded onto the
journal platform during the submission process.

6.4 Ethical Considerations: Human embryos, gametes and/stem cells

Please insert your Ethical Consideration Dr. Kasiatin Widianto, M. Th, as the head committee from Sekolah Tinggi
statement here (include name of ethics Teologi Injili Indonesia Surabaya (Evangelical Theological Seminary of
committee, the institution or
organisation that approved the study Indonesia Surabaya), has approved and examined this research.
protocol or provided guidelines for study
procedures):
Project Research Number: 020023
Ethical Clearance Number: No. 0045/KEP-STTII Sby/EC/III/2023
Date of approval of Ethical Clearance: February, 17th, 2023
I/we certify that informed consent was obtained from all participants (this must be noted in the manuscript.

I/we certify that the ethical clearance certificate, letter or any proof of the approval received for the study will be uploaded onto the
journal platform during the submission process.

6.5 Ethical Considerations: Human research participants

Policy information about studies involving human research participants. Manuscripts involving human research participants or animals
and/or animal-derived materials must include an ethics statement.
Please insert your Ethical Consideration This research which has been approved and examined by Sekolah Tinggi

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 statement here (include name of ethics Teologi Injili Indonesia Surabaya (Evangelical Theological Seminary of
committee, the institution or Indonesia Surabaya), involving human as participant.
organisation that approved the study
protocol or provided guidelines for study
procedures):
Project Research Number: 020023
Ethical Clearance Number: No. 0045/KEP-STTII Sby/EC/III/2023
Date of approval of Ethical Clearance: February, 17th, 2023
I/we certify that informed consent was obtained from all participants (this must be noted in the manuscript.

I/we certify that the ethical clearance certificate, letter, or any proof of the approval received for the study will be uploaded onto the
journal platform during the submission process.

Identifiable Images: For publication of identifiable images or research participants, confirm that consent to publish was obtained and
reflects within the Methods.
Identifiable images in your manuscript? Yes No identifiable images or human
research participants

I/we certify that permission to publish identifiable images or research participants was obtained.

6.6 Ethical Considerations: Waiver received as research was not human or animal research, or the study was determined to be on non-
human subject research.
Manuscripts involving the use of trade statistics, GDP figures, theoretical or conceptual studies, use of secondary non-human data, use of
historical archives, and has no risk may qualify for an Ethics Waiver from the Committee for Research Ethics & Integrity at your
organisation or affiliated institution.
Please insert your Ethical Consideration This research which has been approved and examined by Sekolah Tinggi
statement here (include name of ethics Teologi Injili Indonesia Surabaya (Evangelical Theological Seminary of
committee, the institution or
organisation that approved the study Indonesia Surabaya), used theoretical and conceptual studies, secondary
protocol or provided guidelines for study non-human data, historical archives and has no risk for an Ethics Waiver.
procedures):
Project Research Number: 020023
Ethical Clearance Waiver Number: 0No. 0045/KEP-STTII Sby/EC/III/2023
Date of approval of Ethical Clearance February, 17th, 2023
Waiver:
I/we certify that the ethical clearance certificate, letter, or any proof of the approval received for the study will be uploaded onto the
journal platform during the submission process.

6.7 Clinical studies

It is a requirement for publishing clinical studies that the trial should have been properly reported to a public clinical trials register.
Clinical trial registration I/we have provided the trial registration number from http://www.sanctr.gov.za/ or an
equivalent agency in the manuscript.

Phase 2 and 3 randomised controlled I/we have provided the CONSORT checklist No, this is not a phase 2/3 randomized
trials with our submission. . controlled trial.

Tumour marker prognostic studies I/we have followed the REMARK reporting No, this is not a tumour marker
guidelines. prognostic study.

7. MY CONFIRMATION
In submitting this manuscript (the “Work”) to the Journal published by AOSIS, I hereby warrant, on behalf of myself and my co-authors,
that:

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

v.July2020
 1. I am authorised by my co-authors to enter into these arrangements;
2. I am/we are the sole author(s) of the Work and have full authority to enter into this agreement, and in granting rights to AOSIS
are not in breach of any other obligation;
3. the Work is original, has not been formerly published in any other peer-reviewed journal, is not under consideration by any
other journal and does not infringe any existing copyright or any other third-party rights;
4. we accept that the editor’s decision to publish or reject our Work shall be final, that the editor is under no obligation to provide
any reasons for rejection, and that we shall have no claim against the editor, title owner or publisher resulting from any real or
perceived loss as a result of a rejection;
5. all listed authors have contributed significantly to the Work and preparation of the Work, and they have seen and approved the
content, authorship and affiliations, and order of author representation;
6. the Work contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of
confidence or of commitment given to secrecy;
7. I/we have taken due care to ensure the integrity of the Work. To my/our - and currently accepted scientific - knowledge all
statements contained in it purporting to be facts are true;
8. any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the
user;
9. any research in this Work done on humans or animals (if applicable) adheres to currently applicable and internationally
recognised ethical standards, and recognised ethics committee approval for the research was obtained;
10. any/all personal, employment or commercial affiliations, stock or equity interests or patent-licensing arrangements that could
be considered to pose a conflict of interest regarding the submitted Work (which may potentially prevent them from executing
and publishing unbiased research) have been disclosed to the editor or in the manuscript;
11. we have explicitly identified, credited or referenced the author(s) of data or material taken verbatim from another person’s
work, and we have referenced other authors’ work or ideas, including our own, even if the work or the ideas are not quoted
verbatim or paraphrased, regardless of the origin or the format of dissemination of the work;
12. we have obtained permission for the use of any material in the Work (e.g. graphs and images that are not in the public domain)
that may be under copyright to others, including unpublished material.
13. we accept full responsibility for (a) the payment of any article processing charges/publishing fees (APCs), if applicable, unless
our APCs have been specifically waived, even if responsibility for the payment has been transferred by us to a third party; and
(b) for all costs incurred by AOSIS, or any paid APCs, if the manuscript/article was retracted before or after publication; and (c)
for any Galley Change Fees (GCFs) when we, the author(s), introduce new changes to the text after the typesetting of an article.
We also accept that only one invoice shall be issued per article (no splitting of invoices) in order to expedite publication of the
article and keep costs to a minimum.
14. I/we certify that the above information is complete and correct.

If the Work is accepted for publication, I, and all co-authors, understand and agree that:
1. we grant the title owner of the Journal and AOSIS an irrevocable licence and perpetual subsequent right to be first to (a)
publish, reproduce, distribute, display and store the Work in any form/medium; (b) to translate the Work into other languages,
create adaptations, summaries or extracts of the Work or other derivative works based on the Work and exercise all of the
rights set forth in (a) above in such translations, adaptations, summaries, extracts and derivative works; (c) to licence others to
do any or all of the above; and (d) to register the Digital Object Identifier (DOI) for the final published article appearing in the
journal, including all forms of supplemented material;
2. the Work shall be licensed under the Creative Commons Attribution License 4.0
(http://creativecommons.org/licenses/by/4.0/);
3. ownership of copyright in terms of the Work remains with the authors, who may also post the Work on the authors’ or their
institutions’ websites or institutional repository;
4. the publisher, editors and title owner or the Journal accept no responsibility for any statement made or opinion expressed by
any other person in this Work, and consequently they will not be liable for any loss or damage sustained by any reader as a
result of his or her action upon any statement or opinion in this Work.
THANK YOU
Many thanks for taking the time to complete this form. Your detailed responses will be very helpful in our assessment of your
manuscript’s potential and will enable us to reach a decision regarding suitability for Open Access publication that much sooner. We
remind you to submit this completed cover letter to AOSIS as a supplementary document, at the manuscript submission point on to the
journal website.

Help us improve our customer experiences by knowing what we are doing right and what we can work on, how did you find completing

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

10

v.July2020
 this form? Visit the Feedback Form.

CORRESPONDING AUTHOR TO COMPLETE

Electronic Signature (Automatically Populated)
X Harman Ziduhu Laia /
Harman

11

v.July2020